Natixis Atri Cure, Inc. Transaction History

Natixis

$16 Billion
Q4 2024

A detailed history of Natixis transactions in Atri Cure, Inc. stock. As of the latest transaction made, Natixis holds 60,500 shares of ATRC stock, worth $2.11 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

60,500

Holding current value

$2.11 Million

% of portfolio

0.01%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 13, 2025	BUY	$27.02 - $38.2 $1.63 Million - $2.31 Million	60,500 New	60,500 $1.85 Million
Q1 2024 May 13, 2024	BUY	$28.21 - $37.78 $8.46 Million - $11.3 Million	300,000 New	300,000 $9.13 Million

Others Institutions Holding ATRC

# of Institutions

229

Shares Held

47.1M

Call Options Held

25.8K

Put Options Held

4.5K

Vanguard Group Inc Valley Forge, PA

4.65M
Shares

$162 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.62M
Shares

$161 Million
0.0% of portfolio
Alliancebernstein L.P. New York, NY

3.84M
Shares

$134 Million
0.04% of portfolio
Hood River Capital Management LLC Palm Beach Gardens, FL

2.92M
Shares

$102 Million
1.54% of portfolio
Champlain Investment Partners, LLC Burlington, VT

2.53M
Shares

$88 Million
0.51% of portfolio

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.62B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account